Background: Animal studies show that ovarian hormone defi ciency is associated with development of insulin resistance. In women, the menopause transition marks the cessation of ovarian function and insulin sensitivity would be reduced in postmenopausal women. Aims and Objectives: This study aimed to evaluate the insulin sensitivity in Myanmar postmenopausal women compared to premenopausal women. Materials and Methods: A cross sectional comparative study was undertaken in non obese, normal glucose tolerant post menopausal women (n=42, BMI (mean± SD) 21.3±2.8 kg/m 2 , age 52.6±4.4 years) and premenopausal women (n=33, BMI (mean± SD) 19.7±2.2 kg/m 2 , age32.7±4.9 years). Insulin sensitivity was assessed by homeostasis model assessment method of insulin resistance (HOMA-IR) based on fasting blood glucose and fasting serum insulin level. Blood glucose was determined by glucose oxidase method. Serum insulin was estimated by enzyme linked immunosorbent assay (ELISA). Results: No differences in fasting blood glucose level (Mean ±SD 4.87±0.51 vs. 4.76±0.63mmol/L), fasting serum insulin level [median and interquartile range (IQR) 8.1 (6.7-11.8) vs. 8.1(6.5-9.9) μIU/ml] and HOMA-IR [median and IQR 1.7 (1.4-2.8) vs. 1.7 (1.2-2.2)] were found between premenopausal and postmenopausal women. Conclusion: Postmenopausal status has no effect on insulin sensitivity in postmenopausal women.
INTRODUCTION
Considerable evidences from studies on female rats have showed that ovariectomy decreased insulin-stimulated skeletal muscle glucose uptake. [1] [2] [3] Ovarian hormone defi ciency is associated with the development of insulin resistance. Moreover, ovarian hormones may infl uence glucose uptake by regulating nonoxidative glucose disposal in skeletal muscle. 1, 4 In humans, the menopause transition marks the cessation of ovarian function and dramatic reductions in circulating estrogen and progesterone concentrations. 5 Accordingly, as ovarian hormone levels are reduced after the menopause transition in women, researchers had hypothesized that postmenopausal state might be associated with reduced insulin sensitivity. In support of this hypothesis, an American study by Lindheim et al., 1994 6 measured the insulin sensitivity by insulin tolerance test in 18 premenopausal women and ten postmenopausal women with Insulin tolerance test and frequently sampled intravenous glucose tolerance test (FSIVGTT) and observed a reduction in insulin sensitivity in postmenopausal compared to premenopausal women. Similarly, another cross-sectional observation study involving 28 obese premenopausal and 142 postmenopausal Swedish women also found that postmenopausal women are relatively more insulin resistant than premenopausal ones in comparison with same degree of overall obesity. 7 In this study, insulin sensitivity was measured by IVGTT and EHC methods.
Contrary to this hypothesis, Walton et al., 1993 8 measured insulin sensitivity in 66 premenopausal and 92 postmenopausal Effect of postmenopausal status on insulin sensitivity in myanmar women non-obese Caucasian women with FSIVGTT and reported that measured insulin sensitivity in postmenopausal nonobese Caucasian women was 50% greater than insulin sensitivity in premenopausal women. On other hand, Toth et al., 2000 9 found that there was no change in insulin sensitivity measured by hyperinsulinemic-euglycemic clamp technique between 43 early postmenopausal and 40 premenopausal women from Burlington. A study from North Taiwan 10 measured insulin sensitivity in 380 premenopausal and 234 postmenopausal women with HOMA-IR and showed no signifi cant difference between them. These confl icting and equivocal fi ndings cannot draw defi nite conclusion about the effect of postmenopausal status on insulin sensitivity and further confi rmation studies are needed. Moreover, evidences from Asian populations are limited. Because of ethnic differences in insulin sensitivity, the fi ndings from Western populations could not be extrapolated directly to Asian population.
Thus, this study was intended to evaluate the effect of postmenopausal status on insulin sensitivity in Myanmar women.
MATERIALS AND METHODS

Selection of participants
This was a cross sectional analytical study conducted in the department of Physiology University of Medicine 2, Yangon, Myanmar. Apparently healthy 33 premenopausal women (between 25 and 40 years of aged) and 42 post menopausal women (between 45 and 60 year of age) were recruited in this study. Like previous studies, [11] [12] [13] [14] women with self reported lack of menstruation or spotting for at least 1 year prior to enrolment were classifi ed as post menopausal women. Ethical clearance for conducting the study was obtained from the institutional Ethics committee. Written informed consent was obtained from all subjects. All subjects were examined for a complete medical history taking and physical examination including BMI calculation. Healthy subjects without family history of diabetes, history of chronic smoking and alcohol drinking were included in this study. Then, all participants underwent oral glucose tolerance test (OGTT). After 10-hour overnight fasting, a venous blood sample was taken and then a solution containing 75 gm of glucose anhydrous, in 300 ml of drinking water was given orally. Venous blood was taken again at two hours after the glucose ingestion. Subjects with BMI >25 kg/m 2 , fasting blood glucose >6.1 mmol/L and post-prandial blood glucose >7.8 mmol/L were excluded from this study.
Blood sample analysis
Fasting blood sample were taken after fasting for at least 10 hours. 5 ml of venous blood samples were taken an antecubital vein. 1 ml of blood was collected in tube containing 10 mg of sodium fl uoride for determination of blood glucose and 4 ml of blood was collected in plain tube for serum separation. Tubes were centrifuged at 3000 x g for 10 minutes. After the collection of blood sample, serum was promptly separated and stored at (−20°C) until the blood sample analysis.
Fasting blood glucose was measured by glucose oxidase method (Glucose Liquicolor, Human, D-65205 Wiesbaden, Germany) and serum insulin level was measured by Insulin ELISA (DSL-10-1600, Diagnostic System Laboratories, Inc., Texas, USA) kit method. Insulin sensitivity was calculated by following formulas described by Matthews et al. 15 HOMA-IR = Insulin (μIU/mL) × glucose (mmol/L)/22.5.
Statistical analysis
Data were analyzed by using SPSS software for Window (version 16.0, SPSS Inc., Chicago, IL, USA). All data were expressed as mean ± standard deviation. Skewed data were expressed as median and interquartile range. Difference between those with premenopausal and post-menopausal women were analyzed by using independent two sample t-teat or Mann-Whitney U-test, considering it signifi cant at the p<0.05. Statistical analysis of the three sets of data (non-obese premenopausal, non-obese postmenopausal and overweight postmenopausal) for each analysis was carried out by Bonferroni post-hoc test.
RESULTS
Postmenopausal women were older than premenopausal women signifi cantly (p<0.001). Postmenopausal women have significantly (P <0.001) more BMI, WC and WHR than premenopausal women. SBP and DBP were signifi cantly higher in the postmenopausal women compared to the premenopausal women (Table 1) . FBG. PPBG, fasting serum insulin level and HOMA-IR value were not signifi cantly different between postmenopausal women and the premenopausal women (Table 2) .
DISCUSSION
Present study observed that postmenopausal women have no signifi cant differences in FBG, fasting serum insulin level as compared to premenopausal women. Contrary to this present result, two previous studies 16, 17 reported that mean fasting serum insulin level in postmenopausal women were significantly higher than that in premenopausal women. The postmenopausal women participated in the study of Razay et recruited the premenopausal women and post menopausal women having normal BMI and WC and showed no significant difference in fasting insulin level between premenopausal women and postmenopausal women.
After statistical analysis of data from the present study and other studies shown in Table 3 , the HOMA-IR value of the present study (1.98±0.79) in the all premenopausal women was relatively comparable with those of previous studies [19] [20] [21] [22] whereas it was found to be signifi cantly lower than that of a study conducted by Akin et al., 2007 . 23 The reason for this discrepancy may be due to higher BMI and WC in premenopausal women participated in that study done by Akin et al., 2007. 23 Similarly, the HOMA-IR value (2.52±2.4) of the all postmenopausal women in the present study was relatively comparable with those of studies conducted by Oh et 24 whereas it was found to be signifi cantly lower than that of a study conducted by Ahren and Larsson, 2002. 26 Like previous studies 9 , 23 the present study also showed that there was no signifi cant difference between premenopausal and postmenopausal women. Contrary to this, two studies of Lindheim et al., 1994 6 and Nilsson et al., 2000 27 have reported that insulin sensitivity was reduced in post menopausal women. Post menopausal women have increased tendency to be obese with advancing age and more sedentary life style. 28, 29 It was also noted that postmenopausal women recruited in previous studies 6, 27 were associated with increased BMI and central adiposity. Accordingly, HOMA-IR was signifi cantly and positively correlated with BMI and WC. [30] [31] [32] It can be assumed that increased insulin resistance of these postmenopausal women may be due in part to increased BMI and central obesity and did not entirely refl ect the effect of menopausal status. Many studies required to evaluate whether decrease in insulin sensitivity after the menopause is related to menopause itself or change in body composition. In their fi nding, it was shown that there was no signifi cant difference of insulin sensitivity between premenopausal and postmenopausal women. Similarly, present study intentionally recruited all the non-obese premenopausal and postmenopausal women (BMI < 25kg/m 2 ) to reduce the confounding infl uence of obesity and high level of body fat on insulin sensitivity. In the present study, BMI of postmenopausal women were signifi cantly higher than that of premenopausal women even they are in normal range, If this BMI difference might effect on insulin sensitivity, HOMA-IR value of insulin resistance would be increase in postmenopausal women. However HOMA-IR value was no signifi cantly different between pre-and postmenopausal groups. According to the study of DeNino et al. (2001) 18 , signifi cant reduction in insulin sensitivity was not found until 60 years of age. The postmenopausal women participated in the present study were 45-60 years old. Thus age difference between postmenopausal women (older) and premenopausal women were negligible effect on insulin sensitivity. In the light of the present study, it could be assumed that menopause itself do not affect insulin sensitivity in non-obese postmenopausal women. Previous studies [33] [34] [35] reported that obesity after menopause resulted in insulin resistance. In the present study, 45% of postmenopausal women were overweight according to BMI>= 23 kg/m 2 (Asian people). 36 The HOMA-IR value of overweight postmenopausal women (19 out of 42 postmenopausal women) was signifi cantly higher than that of non-obese premenopausal (n-29) and postmenopausal women (n=23) ( Table 4) . Not only obese postmenopausal women but also overweight postmenopausal women resulted in insulin resistance after menopause. So BMI and WC were signifi cant predictors of insulin resistance in post menopausal women. It could be assumed that menopause itself does not affect insulin sensitivity.
CONCLUSION
This study shows that there was no signifi cant difference of insulin sensitivity between non-obese premenopausal and non-obese postmenopausal women. Observed decrease of insulin sensitivity in overweight postmenopausal women may be due to increased total and intra-abdominal fat. Only hormonal imbalance after menopause does not infl uence insulin sensitivity. BMI and WC are also strong predictors of insulin resistance. In the light of present study, it could be assumed that menopause itself do not affect insulin sensitivity.
RECOMMENDATION
Signifi cant reduction in insulin sensitivity was not found until 60 years of age and decreased insulin sensitivity was noted only in more than 60 years old women who were 10-15 years postmenopausal 20 . Physical activity, diet and genetic factor also infl uence the insulin sensitivity, and insulin sensitivity varies between individuals. So, further longitudinal study is also recommended to examine the change of insulin sensitivity from premenopausal to postmenopausal state in the same individual. 
